The Urokinase Receptor Takes Control of Cell Migration by Recruiting Integrins and FPR1 on the Cell Surface

The receptor (uPAR) of the urokinase-type plasminogen activator (uPA) is crucial in cell migration since it concentrates uPA proteolytic activity at the cell surface, binds vitronectin and associates to integrins. uPAR cross-talk with receptors for the formylated peptide fMLF (fMLF-Rs) has been reported; however, cell-surface uPAR association to fMLF-Rs on the cell membrane has never been explored in detail. We now show that uPAR co-localizes at the cell-surface and co-immunoprecipitates with the high-affinity fMLF-R, FPR1, in uPAR-transfected HEK-293 (uPAR-293) cells. uPAR/β1 integrin and FPR1/β1 integrin co-localization was also observed. Serum or the WKYMVm peptide (W Pep), a FPR1 ligand, strongly increased all observed co-localizations in uPAR-293 cells, including FPR1/β1 integrin co-localization. By contrast, a low FPR1/β1 integrin co-localization was observed in uPAR-negative vector-transfected HEK-293 (V-293) cells, that was not increased by serum or W Pep stimulations. The role of uPAR interactions in cell migration was then explored. Both uPAR-293 and V-293 control cells efficiently migrated toward serum or purified EGF. However, cell treatments impairing uPAR interactions with fMLF-Rs or integrins, or inhibiting specific cell-signaling mediators abrogated uPAR-293 cell migration, without exerting any effect on V-293 control cells. Accordingly, uPAR depletion by a uPAR-targeting siRNA or uPAR blocking with an anti-uPAR polyclonal antibody in cells constitutively expressing high uPAR levels totally impaired their migration toward serum. Altogether, these results suggest that both uPAR-positive and uPAR-negative cells are able to migrate toward serum; however, uPAR expression renders cell migration totally and irreversibly uPAR-dependent, since it is completely inhibited by uPAR blocking. We propose that uPAR takes control of cell migration by recruiting fMLF-Rs and β1 integrins, thus promoting their co-localization at the cell-surface and driving pro-migratory signaling pathways.

[1]  D. Ye,et al.  Molecular biology for formyl peptide receptors in human diseases , 2013, Journal of Molecular Medicine.

[2]  Daniela Alfano,et al.  uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors , 2012, Thrombosis and Haemostasis.

[3]  C. Arra,et al.  Single Amino Acid Substitutions in the Chemotactic Sequence of Urokinase Receptor Modulate Cell Migration and Invasion , 2012, PloS one.

[4]  A. Ridley,et al.  RhoB regulates uPAR signalling , 2012, Journal of Cell Science.

[5]  C. Selleri,et al.  The urokinase-receptor in infectious diseases. , 2012, Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive.

[6]  A. Sonnenberg,et al.  Regulation of integrin function and trafficking , 2013 .

[7]  A. Ridley Life at the Leading Edge , 2011, Cell.

[8]  Ronan P. Murphy,et al.  The urokinase receptor interactome. , 2011, Current pharmaceutical design.

[9]  Daniela Alfano,et al.  The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor , 2011, Cellular and Molecular Life Sciences.

[10]  E. Sariban,et al.  Crosstalks between the receptors tyrosine kinase EGFR and TrkA and the GPCR, FPR, in human monocytes are essential for receptors-mediated cell activation. , 2010, Cellular signalling.

[11]  C. Marshall,et al.  Regulation of cell signalling by uPAR , 2010, Nature Reviews Molecular Cell Biology.

[12]  P. Ragno,et al.  Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR. , 2009, Frontiers in bioscience.

[13]  M. Ploug,et al.  Structure and ligand interactions of the urokinase receptor (uPAR). , 2008, Frontiers in bioscience : a journal and virtual library.

[14]  Y. Wei,et al.  The urokinase receptor and integrins in cancer progression , 2008, Cellular and Molecular Life Sciences.

[15]  Enrico Gratton,et al.  Monomer–dimer dynamics and distribution of GPI-anchored uPAR are determined by cell surface protein assemblies , 2007, The Journal of cell biology.

[16]  X. Bian,et al.  Transactivation of the epidermal growth factor receptor by formylpeptide receptor exacerbates the malignant behavior of human glioblastoma cells. , 2007, Cancer research.

[17]  G. Rossi,et al.  In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. , 2006, Cancer research.

[18]  O. Liang,et al.  A Region in Urokinase Plasminogen Receptor Domain III Controlling a Functional Association with α5β1 Integrin and Tumor Growth* , 2006, Journal of Biological Chemistry.

[19]  F. Blasi,et al.  An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration. , 2005, Molecular biology of the cell.

[20]  O. Liang,et al.  A region in urokinase plasminogen receptor domain III controlling a functional association with alpha5beta1 integrin and tumor growth. , 2006, The Journal of biological chemistry.

[21]  P. Ragno,et al.  The urokinase receptor: a ligand or a receptor? Story of a sociable molecule , 2006, Cellular and Molecular Life Sciences CMLS.

[22]  R. Czekay,et al.  Domain 2 of the Urokinase Receptor Contains an Integrin-interacting Epitope with Intrinsic Signaling Activity , 2005, Journal of Biological Chemistry.

[23]  G. Rossi,et al.  Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. , 2005, Blood.

[24]  G. Rossi,et al.  Soluble and cleaved forms of the urokinase-receptor: degradation products or active molecules? , 2005, Thrombosis and Haemostasis.

[25]  V. Basso,et al.  The soluble D2D388-274 fragment of the urokinase receptor inhibits monocyte chemotaxis and integrin-dependent cell adhesion , 2004, Journal of Cell Science.

[26]  F. Blasi,et al.  Dimerization controls the lipid raft partitioning of uPAR/CD87 and regulates its biological functions , 2003, The EMBO journal.

[27]  L. Trusolino,et al.  Interactions between growth factor receptors and adhesion molecules: breaking the rules. , 2003, Current opinion in cell biology.

[28]  S. Salzano,et al.  The Cleavage of the Urokinase Receptor Regulates Its Multiple Functions* , 2002, The Journal of Biological Chemistry.

[29]  Philip M Murphy,et al.  Formyl-peptide receptors revisited. , 2002, Trends in immunology.

[30]  L. Ossowski,et al.  EGFR is a transducer of the urokinase receptor initiated signal that is required for in vivo growth of a human carcinoma. , 2002, Cancer cell.

[31]  Kenneth M. Yamada,et al.  Integrin regulation of growth factor receptors , 2002, Nature Cell Biology.

[32]  Ji Ming Wang,et al.  The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[33]  U. Weidle,et al.  Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. , 2001, The Biochemical journal.

[34]  A. Jesaitis,et al.  Chemotaxis of chinese hamster ovary cells expressing the human neutrophil formyl peptide receptor: role of signal transduction molecules and alpha5beta1 integrin. , 1998, Journal of cell science.

[35]  D. Staunton,et al.  Differential regulation of chemoattractant-stimulated beta 2, beta 3, and beta 7 integrin activity. , 1998, Journal of immunology.

[36]  E. Appella,et al.  A urokinase‐sensitive region of the human urokinase receptor is responsible for its chemotactic activity , 1997, The EMBO journal.

[37]  Michael V. Doyle,et al.  Regulation of Integrin Function by the Urokinase Receptor , 1996, Science.

[38]  C. Mackay,et al.  Biology of chemokine and classical chemoattractant receptors: differential requirements for adhesion-triggering versus chemotactic responses in lymphoid cells , 1996, The Journal of cell biology.

[39]  O. Majdic,et al.  Urokinase plasminogen activator receptor, beta 2-integrins, and Src- kinases within a single receptor complex of human monocytes , 1995, The Journal of experimental medicine.

[40]  S. Rosenberg,et al.  Identification of the urokinase receptor as an adhesion receptor for vitronectin. , 1994, The Journal of biological chemistry.

[41]  M. Gyetko,et al.  The urokinase receptor is required for human monocyte chemotaxis in vitro. , 1994, The Journal of clinical investigation.